A mortality risk prediction model for older adults with lymph node-positive colon cancer.

Clinicians are less likely to recommend adjuvant chemotherapy for older adults based on their age alone. This study aimed to develop a mortality risk model to assist treatment decision making by identifying patients who are unlikely to live to benefit from chemotherapy. All lymph node-positive colon cancer patients ≥65 years who received surgery in New South Wales, Australia in 2007/2008 were identified using a linked population-based dataset (n = 1550). A model predicting 1-year all-cause mortality was built using multilevel logistic regression. Risk scores derived from model factors were summed for each patient. One-year mortality was 11.5%. The risk model consisted of 14 factors, including comorbidities, hospital admission factors and other markers of frailty or health status. People with a total score of 0, 1 or 2 were considered at low risk (predicted 1-year mortality of 2.9%), those scoring 3 to 8 at medium risk (7.4% mortality) and those scoring 9 or above at high risk (24.7% mortality). The model had good discrimination (area under the receiver operating characteristic curve = 0.788, 95% confidence interval: 0.752-0.825) and calibration (P = 0.46). The risk model accurately predicts mortality for this cohort and could be useful in shifting the emphasis in chemotherapy decision making from chronological age to the identification of those of any age who will benefit.

[1]  J. Silver,et al.  Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. , 2013, American journal of physical medicine & rehabilitation.

[2]  M. Coleman,et al.  Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007 , 2013, Acta oncologica.

[3]  Cheng-Le Zhuang,et al.  Enhanced Recovery After Surgery Programs Versus Traditional Care for Colorectal Surgery: A Meta-analysis of Randomized Controlled Trials , 2013, Diseases of the colon and rectum.

[4]  R. Nelson,et al.  Elderly patients with colon cancer have unique tumor characteristics and poor survival , 2013, Cancer.

[5]  B. Armstrong,et al.  Using administrative health data to describe colorectal and lung cancer care in New South Wales, Australia: a validation study , 2012, BMC Health Services Research.

[6]  B. V. van Munster,et al.  Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. , 2012, The Lancet. Oncology.

[7]  S. Alibhai,et al.  Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review , 2012, Journal of the National Cancer Institute.

[8]  G. Lyman,et al.  Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score , 2012, Cancer.

[9]  H. Wildiers,et al.  Comprehensive geriatric assessment (CGA) in older oncological patients: Why and how? , 2012 .

[10]  C. V. D. van de Velde,et al.  Risk Factors for Excess Mortality in the First Year After Curative Surgery for Colorectal Cancer , 2012, Annals of Surgical Oncology.

[11]  J. Dhesi,et al.  Frailty in the older surgical patient: a review. , 2012, Age and ageing.

[12]  Mara A Schonberg,et al.  Prognostic indices for older adults: a systematic review. , 2012, JAMA.

[13]  E. Vicaut,et al.  Mortality After Colorectal Cancer Surgery: A French Survey of More Than 84,000 Patients , 2011, Annals of surgery.

[14]  Sathya Karunananthan,et al.  The Identification of Frailty: A Systematic Literature Review , 2011, Journal of the American Geriatrics Society.

[15]  Sven E. Wilson,et al.  Marital status and colon cancer outcomes in US Surveillance, Epidemiology and End Results registries: does marriage affect cancer survival by gender and stage? , 2011, Cancer epidemiology.

[16]  Supriya G Mohile,et al.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Rowell,et al.  Additional costs of inpatient malnutrition, Victoria, Australia, 2003–2004 , 2011, The European Journal of Health Economics.

[18]  W. Mackillop,et al.  Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. , 2011, JAMA.

[19]  E. Bastiaannet,et al.  Importance of the First Postoperative Year in the Prognosis of Elderly Colorectal Cancer Patients , 2011, Annals of Surgical Oncology.

[20]  Bing Li,et al.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.

[21]  Jane M. Young,et al.  Older Patients and Adjuvant Therapy for Colorectal Cancer: Surgeon Knowledge, Opinions, and Practice , 2011, Diseases of the colon and rectum.

[22]  N. Tomita,et al.  Does 1 year adjuvant chemotherapy with oral 5-FUs in colon cancer reduce the peak of recurrence in 1 year and provide long-term OS benefit? , 2011, Japanese journal of clinical oncology.

[23]  R. Labianca,et al.  Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  Maureen A Smith,et al.  Readmission After Colectomy for Cancer Predicts One-Year Mortality , 2010, Annals of surgery.

[25]  P. New,et al.  The Costs and Adverse Events Associated With Hospitalization of Patients With Spinal Cord Injury in Victoria, Australia , 2010, Spine.

[26]  Patrick Royston,et al.  Reporting performance of prognostic models in cancer: a review , 2010, BMC medicine.

[27]  S. Tezenas du Montcel,et al.  Elderly POSSUM, a dedicated score for prediction of mortality and morbidity after major colorectal surgery in older patients , 2010, The British journal of surgery.

[28]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: Developing a prognostic model , 2009, BMJ : British Medical Journal.

[29]  C. Earle,et al.  Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. , 2009, Journal of the American College of Surgeons.

[30]  G. Beretta,et al.  Colorectal cancer treatment in elderly patients: an update on recent clinical studies. , 2008, Clinical colorectal cancer.

[31]  F. Prall,et al.  Colorectal cancer in the elderly—surgical treatment and long-term survival , 2008, International Journal of Colorectal Disease.

[32]  Sophia Rabe-Hesketh,et al.  Multilevel and Longitudinal Modeling Using Stata, Second Edition , 2008 .

[33]  D. Meltzer,et al.  A prognostic model for 1-year mortality in older adults after hospital discharge. , 2007, The American journal of medicine.

[34]  R. Audisio,et al.  Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. , 2006, Surgical oncology.

[35]  R. Audisio,et al.  Prediction of Postoperative Mortality in Elderly Patients With Colorectal Cancer , 2006, Diseases of the colon and rectum.

[36]  Karla Lindquist,et al.  Development and validation of a prognostic index for 4-year mortality in older adults. , 2006, JAMA.

[37]  S. Cha,et al.  Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[39]  P. Ravdin,et al.  Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  J. Scholefield,et al.  Screening for colorectal cancer reduces emergency admissions. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[41]  W. Mackillop,et al.  Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer , 2011 .

[42]  J. Coebergh,et al.  Cancer survival in the elderly: effects of socio-economic factors and health care system features (ELDCARE project). , 2006, European journal of cancer.

[43]  S. Guthridge,et al.  Socio-economic indexes for areas (SEIFA) of administrative health districts and urban centres/localities in the Northern Territory , 2005 .

[44]  H. Anton-Culver,et al.  Screening for colorectal cancer [1] (multiple letters) , 2000 .